Market Cap
$6.0B
KOD
Kodiak Sciences Inc.
$94.45 ▼ -4.07%
Prev close $98.46Market cap$6.0B
ConsensusStrong Buy
12-mo target$116.67 (+23.5%)
▲ Bullish
Analyst conviction 9/10
High Impact Filing (8/10)27 New Institutional Positions14 Institutional Exits Biotech & Drug Discovery
Snapshot
The big-picture read on KOD right now — valuation, ownership and activity at a glance.
Cap Size
Mid Cap
Analyst Consensus
Strong Buy (90%)
Inst. Holders
50 funds
Inst. Value
$1.7B
Inst. Activity
27 buys / 14 sells
Insider Activity
$99.5M buy / $0.00 sell
Insider Net $
$99.5M
Social Sentiment
50° Neutral
SEC Reports
5
Price chart 30d +159.8%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 1, 2026 short_volume
Short Volume: KOD — 58.4% short (1.0M / 1.7M)
Short: 972,905 | Exempt: 0 | TRF Vol: 1,666,935 | Short Ratio: 58.4% | Off-exchange volume (dark poo
Sep 29, 2026 Insider
BAKER BROS. ADVISORS LP bought 1,416 shares
Director @ $85.89 ($121.6K)
Sep 29, 2026 Insider
BAKER BROS. ADVISORS LP bought 619 shares
Director @ $84.24 ($52.1K)
Sep 29, 2026 Insider
Aug 13, 2026 SEC BAKER BROS. ADVISORS LP bought 1,195 shares
Director @ $85.40 ($102.1K)
Kodiak Sciences reported Q2 2026 net loss of $65.6M ($1.05/share), wider than the $54.3M loss in Q2 2025, with R&D spend
PRESS-RELEASE — Impact 6/10
Kodiak Sciences reported Q2 2026 financial results with a net loss of $65.6M ($1.05/share), wider than the $54.3M loss i
8-K — Impact 4/10
Jun 30, 2026 Inst.
GOLDMAN SACHS GROUP INC — ADD
2,316,014 shares ($90.2M)
Jun 30, 2026 Inst.
Artisan Partners Limited Partnership — ADD
968,037 shares ($37.7M)
Analyst ratings buy % +34.3%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
90% rate it Buy or better · 10 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Sep 28, 2026 | LifeSci Capital | MAINTAIN | Outperform | 50% |
| Sep 28, 2026 | UBS | MAINTAIN | Buy | 55% |
| Sep 28, 2026 | HC Wainwright & Co. | MAINTAIN | Buy | 43% |
| Sep 17, 2026 | HC Wainwright & Co. | REITERATE | Buy | 43% |
| Aug 17, 2026 | HC Wainwright & Co. | REITERATE | Buy | 43% |
| Aug 3, 2026 | JP Morgan | MAINTAIN | Overweight | 55% |
| May 11, 2026 | Chardan Capital | UPGRADE | Buy | 49% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 2 | 7 | 1 | 0 | 0 | 90% | |
| Aug 1, 2026 | 2 | 7 | 1 | 0 | 0 | 90% | |
| Jul 1, 2026 | 2 | 8 | 1 | 0 | 0 | 91% | |
| Jun 1, 2026 | 2 | 8 | 1 | 0 | 0 | 91% | |
| May 1, 2026 | 2 | 7 | 2 | 0 | 0 | 82% | |
| Apr 1, 2026 | 2 | 7 | 2 | 0 | 0 | 82% | |
| Mar 1, 2026 | 2 | 7 | 2 | 0 | 0 | 82% | |
| Feb 1, 2026 | 2 | 7 | 2 | 1 | 0 | 75% |
Price targets
Where 6 covering analysts think KOD trades over the next 12 months.
$116.67 +23.5% upside Strong Buy
Current$94.45 Low$96.00 Median$116.00 High$145.00 6 analysts
$96.00$145.00
Analyst rating Strong Buy· 1.4/5 as of Oct 2, 2026
Social media sentiment mood -12.0%
Retail-investor mood aggregated across social media. 0° = very bearish, 100° = very bullish.
50°
Neutral
BearishNeutralBullish
Recent posts
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
5 SEC filing reports analyzed · 2 bullish, 0 bearish, 0 mixed, 3 neutral · avg impact 5.2/10.
NEUTRALPRESS-RELEASE6/10
Kodiak Sciences reported Q2 2026 net loss of $65.6M ($1.05/share), wider than the $54.3M loss in Q2
Aug 13, 2026
NEUTRAL8-K4/10
Kodiak Sciences reported Q2 2026 financial results with a net loss of $65.6M ($1.05/share), wider th
Aug 13, 2026
BULLISHINST-CLUSTER4/10
Four mega-passive institutional investors (T. Rowe Price, Invesco, BofA, Morgan Stanley) aggressivel
Jun 11, 2026
NEUTRAL8-K4/10
Kodiak Sciences reported Q1 2026 net loss of $58.2M ($0.94/share) vs $57.5M ($1.09/share) in Q1 2025
May 7, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Oct 1, 2026
short_volume
Short Volume: KOD — 58.4% short (1.0M / 1.7M)
Short: 972,905 | Exempt: 0 | TRF Vol: 1,666,935 | Short Ratio: 58.4% | Off-exchange volume (dark pool + OTC)
Sep 30, 2026
short_volume
Short Volume: KOD — 65.8% short (1.6M / 2.4M)
Short: 1,558,114 | Exempt: 32,518 | TRF Vol: 2,368,969 | Short Ratio: 65.8% | Off-exchange volume (dark pool + OTC)
Sep 29, 2026
short_volume
Short Volume: KOD — 64.8% short (2.1M / 3.2M)
Short: 2,069,922 | Exempt: 45,881 | TRF Vol: 3,196,276 | Short Ratio: 64.8% | Off-exchange volume (dark pool + OTC)
Sep 28, 2026
short_volume
Short Volume: KOD — 61.2% short (12.1M / 19.8M)
Short: 12,137,263 | Exempt: 156,081 | TRF Vol: 19,822,909 | Short Ratio: 61.2% | Off-exchange volume (dark pool + OTC)
Sep 25, 2026
routine
Kodiak Sciences to Present Topline Results on September 28, 2026 from DAYBREAK Pivotal Phase 3 Study of Zenkuda and KSI-501 in Patients with Wet Age-Related Macular Degeneration
Kodiak Sciences to Host Webcast on Monday, September 28 at 8:30 AM Eastern Time PALO ALTO, Calif., Sept. 25, 2026 /PRNewswire/ -- Kodiak Sciences Inc.
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $-1.01 | $-1.10–$-0.89 | 12.9% | +0.2% | 0↑ 5↓ | $0.0B | 5 |
| Next Q | $-0.98 | $-1.11–$-0.89 | 5.3% | +0.4% | 0↑ 5↓ | $0.0B | 5 |
| Current FY | $-3.98 | $-4.20–$-3.75 | 7.8% | +0.2% | 0↑ 5↓ | $0.0B | 5 |
| Next FY | $-3.44 | $-4.92–$-1.99 | 13.7% | +8.3% | 0↑ 4↓ | $0.0B | 4 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $-1.011 | — |
| 7d ago | $-1.013 | +0.002 |
| 30d ago | $-1.013 | +0.002 |
| 60d ago | $-0.922 | -0.089 |
| 90d ago | $-0.931 | -0.079 |
Institutional ownership
Which big funds own KOD (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $1.7B total value (43,859,073 shares) as of 2026-Q2. Top holders: BAKER, BlackRock,, STATE. Net buying activity: 27 institutions added/increased vs 14 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 19,919,186 | $776.1M | 45.4% | — |
| BlackRock, Inc. | 4,135,355 | $161.1M | 9.4% | — |
| STATE STREET CORP | 2,419,417 | $94.3M | 5.5% | ADD +30.0% |
| GOLDMAN SACHS GROUP INC | 2,316,014 | $90.2M | 5.3% | ADD +37.1% |
| VANGUARD CAPITAL MANAGEMENT LLC | 1,804,632 | $70.3M | 4.1% | — |
| Jupiter Topco LLC | 1,526,006 | $59.5M | 3.5% | — |
| RTW INVESTMENTS, LP | 1,487,934 | $58.0M | 3.4% | — |
| GEODE CAPITAL MANAGEMENT, LLC | 1,062,955 | $41.4M | 2.4% | — |
| Artisan Partners Limited Partnership | 968,037 | $37.7M | 2.2% | ADD +40.2% |
| WELLINGTON MANAGEMENT GROUP LLP | 793,613 | $30.9M | 1.8% | ADD +81.9% |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| GOLDMAN SACHS GROUP INC | ADD | 1,689,003 | 2,316,014 | +37.1% | $90.2M |
| Artisan Partners Limited Partnership | ADD | 690,322 | 968,037 | +40.2% | $37.7M |
| WELLINGTON MANAGEMENT GROUP LLP | ADD | 436,329 | 793,613 | +81.9% | $30.9M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | ADD | 365,051 | 532,819 | +46.0% | $20.8M |
| BANK OF AMERICA CORP /DE/ | ADD | 300,356 | 383,709 | +27.8% | $14.9M |
| FMR LLC | ADD | 183,919 | 276,984 | +50.6% | $10.8M |
| RENAISSANCE TECHNOLOGIES LLC | TRIM | 294,300 | 189,200 | -35.7% | $7.4M |
| Nuveen, LLC | ADD | 95,292 | 174,730 | +83.4% | $6.8M |
| CITADEL ADVISORS LLC | NEAR_EXIT | 870,788 | 157,524 | -81.9% | $6.1M |
| Squarepoint Ops LLC | DOUBLED | 71,056 | 151,098 | +112.6% | $5.9M |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
1 insiders, 50 transactions. Net $99.5M — $99.5M bought, $0.00 sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 29, 2026 | BAKER BROS. ADVISORS LP | Director | BUY | 1,416 | $85.89 | $121.6K |
| Sep 29, 2026 | BAKER BROS. ADVISORS LP | Director | BUY | 619 | $84.24 | $52.1K |
| Sep 29, 2026 | BAKER BROS. ADVISORS LP | Director | BUY | 1,195 | $85.40 | $102.1K |
| Sep 29, 2026 | BAKER BROS. ADVISORS LP | Director | BUY | 10,381 | $84.24 | $874.5K |
| Sep 29, 2026 | BAKER BROS. ADVISORS LP | Director | BUY | 20,031 | $85.40 | $1.7M |
| Sep 29, 2026 | BAKER BROS. ADVISORS LP | Director | BUY | 84 | $85.89 | $7.2K |
| Sep 28, 2026 | BAKER BROS. ADVISORS LP | Director | BUY | 884 | $79.71 | $70.5K |
| Sep 28, 2026 | BAKER BROS. ADVISORS LP | Director | BUY | 5,880 | $88.57 | $520.8K |
| Sep 28, 2026 | BAKER BROS. ADVISORS LP | Director | BUY | 196,608 | $89.86 | $17.7M |
| Sep 28, 2026 | BAKER BROS. ADVISORS LP | Director | BUY | 2,666 | $61.63 | $164.3K |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for KOD.
Shares short
10,672,646
Settlement Sep 15, 2026
Change vs prior
-1.0%
Semi-monthly cycle
Days to cover
17.9
At avg daily volume
Of shares outstanding
≈17.0%
Estimate — not % of float
All KOD filing & press-release reports (5)
- PRESS-RELEASE reportAug 13, 2026
- 8-K reportAug 13, 2026
- INST-CLUSTER reportJun 11, 2026
- 8-K reportMay 7, 2026
- 8-K reportApr 21, 2026